CD20 antibodies induce production and release of reactive oxygen species by neutrophils

Blood. 2014 Jun 19;123(25):4001-2. doi: 10.1182/blood-2014-05-574285.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived / immunology*
  • Antibodies, Monoclonal, Murine-Derived / pharmacology
  • Antigens, CD20 / immunology*
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Cells, Cultured
  • Coculture Techniques
  • Enzyme Inhibitors / immunology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Luminescent Measurements / methods
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / immunology
  • NADPH Oxidases / metabolism
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Neutrophils / metabolism
  • Onium Compounds / immunology
  • Onium Compounds / pharmacology
  • Reactive Oxygen Species / immunology*
  • Reactive Oxygen Species / metabolism
  • Rituximab
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Enzyme Inhibitors
  • Onium Compounds
  • Reactive Oxygen Species
  • Rituximab
  • diphenyleneiodonium
  • NADPH Oxidases
  • ofatumumab